Advanced Search

Home > Journals > Minerva Pneumologica > Past Issues > Minerva Pneumologica 2003 December;42(4) > Minerva Pneumologica 2003 December;42(4):233-44



A Journal on Diseases of the Respiratory System

Official Journal of the Italian Society of Thoracic Endoscopy
Indexed/Abstracted in: EMBASE, Scopus

Frequency: Quarterly

ISSN 0026-4954

Online ISSN 1827-1723


Minerva Pneumologica 2003 December;42(4):233-44


Orally exhaled nitric oxide as a markerof inflammation in childhood asthma

Silvestri M., Sabatini F., Serpero L., Petecchia L., Rossi G. A.

Airway inflammation is a key process involved in asthma since mediators released by inflammatory cells may induce acute damages and structural changes to the airways. Airway inflammation is, therefore, a primary therapeutic goal and the treatment with anti-inflammatory drugs should be started as early as possible in order to avoid irreversible airway remodelling occurring during chronic inflammation, even in young children. The need to monitor inflammation has led to the exploration of volatile compound in exhaled air. Nitric oxide (NO) is being increasingly used to assess airway inflammation in childhood. Moreover, it has become clear in the last few years that increased NO is present in the expired air of patients with asthma and that measurement of the fractional concentration of exhaled NO (FENO) may represent a non invasive, simple, well tolerated test thought to reflect the airway inflammatory events in asthmatic children.

language: English


top of page